Pharmacokinetics and pharmacodynamics of gliclazide in Caucasians and Australian Aborigines with type 2 diabetes

AIMS: Gliclazide pharmacokinetics and pharmacodynamics were assessed in 9 Caucasians and 10 Australian Aborigines with uncomplicated type 2 diabetes. METHODS: Subjects were on a stable dose of 80 mg gliclazide twice daily, took 160 mg on the morning of study and had a standard breakfast. No further...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Davis, Timothy M E, Daly, Frank, Walsh, John P, Ilett, Kenneth F, Beilby, John P, Dusci, Leon J, Barrett, P Hugh R
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Blackwell Science Inc 2000
Konular:
Pharmacokinetics/Pharmacodynamics
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2014921/
https://ncbi.nlm.nih.gov/pubmed/10718777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2125.2000.00162.x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller